Manuales, Vilma B.

HRN: 21-47-49  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/15/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/15/2022
08/22/2022
IV
1.5g
Q6
CAP MR
Waiting Final Action 
08/15/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/17/2022
08/23/2022
IV
4.5g
Q6
Sepsis
Waiting Final Action 
08/23/2022
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
08/23/2022
08/29/2022
IV
750mg
Q25hrs
CAP-HR/HAP
Waiting Final Action 
08/24/2022
CEFTAZIDIME 1GM (VIAL)
08/24/2022
08/30/2022
IV
1g
Q8H
Community Acquired Pneumonia - Moderate Risk
Waiting Final Action 
09/02/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/02/2022
09/08/2022
IVT
4.5g
Q6
Pulmonary Mass, CAP-MR
Waiting Final Action 
09/03/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
09/03/2022
09/09/2022
IVT
600mg
Q8 X 7 Days
Ptb, Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: